Transthyretin Amyloidosis Treatment Market Size, Share & Industry Analysis, By Drug (Inostersen, Partisiran, Tafamidis, Others), By Indication (Wild Type ATTR amyloidosis, Hereditary ATTR amyloidosis), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) and Regional Forecast, 2023-2030
Report Id | License Type | Price |
---|---|---|
FBI101886 | $ 4850 | |
Total | $ 4850 |